Canada markets open in 2 hours 9 minutes

MRK May 2024 125.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
4.5500-1.8100 (-28.46%)
As of 02:36PM EDT. Market open.
Full screen
Loading interactive chart...
  • Business Wire

    Merck to Acquire EyeBio

    RAHWAY, N.J. & NEW YORK, May 29, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.

  • Reuters

    Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

    Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.

  • Investing.com

    Merck nears $1.3 bln takeover of Eyebiotech- WSJ

    Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.